Table 2.

Liver data (n = 56)

Liver haemodynamics
Free hepatic venous pressure (mm Hg)	16 ± 4 (17 [14-19])
Wedged hepatic venous pressure (mm Hg)	17 ± 5 (18 [14-20])
Hepatic venous pressure gradient (mm Hg)	1.4 ± 0.3 (1 [0-2])
Liver biopsy
Sinusoidal dilation	56 (100%)
Sinusoidal fibrosis (categories 1-4)	56 (100%)
Portal fibrosis (categories 1-4)	54 (94%)
Liver disease severity
VAST (normal < 1) (n = 14)	2.3 ± 1.0
APRI (normal < 0.3)	0.5 ± 0.2
Child-Pugh score (normal < 5)	6 ± 2
MELD score (normal < 6)	13 ± 2
MELD-XI score (normal < 11)	10 ± 2
Liver function
AST (U/L) (normal 8-43)	39 (27-61)
ALT (U/L) (normal 7-45)	41 (29-76)
ALP (U/L) (normal 37-104)	92 (63-128)
Total bilirubin (mg/dL) (normal 0.1-1.2)	1.3 (0.8-1.8)
Direct bilirubin (mg/dL) (normal 0-0.3)	0.3 (0.1-0.6)
Albumin (g/dL) (normal 3.5-5.0)	3.9 (3.2-4.1)
Alpha-fetoprotein (ng/mL) (normal < 0.6)	3 (1-7)
INR∗ (normal < 1.2)	2.4 (1.8-2.9)
INR† (normal < 1.2)	1.3 (1.0-1.5)
Platelet (×109/L) (normal 150-450)	153 (122-264)

Data are presented as mean ± standard deviation and median (interquartile range).

ALP, alkaline phosphatase; ALT, alanine aminotransferase; APRI, aspartate aminotransferase to platelet ratio index; AST, aspartate aminotransferase; INR international normalized ratio; MELD, model for end-stage liver disease; MELD-XI, model of end-stage liver disease excluding INR; VAST, varices, ascites, splenomegaly, and thrombocytopenia.

^∗INR in all patients.

^†INR excluding patients receiving warfarin